SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Q: What does CUSIP 78397T202 represent in this 13F holders report?

CUSIP 78397T202 is the security identifier for SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q2 2026?

86 institutional investors reported SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 78397T202

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 68,397,312
Total 13F value: $266,750,251
Share change: -802,325
Put/Call ratio: 139%
SEC-reported price per share: $3.90
Number of holders: 86
Value change: -$2,811,505
Number of buys: 55
Number of sells: 37
Shares outstanding: 226,597,678

Security key

78397T202

Report period

Q2 2026

Institutions

Top holders

SABS full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 SAB Biotherapeutics, Inc. SEC filings SAB Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 78397T202

Previous quarter: Q4 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Vivo Opportunity Fund Hol...

Disclosed value leader

Vivo Opportunity Fund Hol...

Comparable rows

15/15

Latest evidence

30 Jun 2026

13D/G 13F Lead comparable stake: 10% 13D/G row: Vivo Opportunity Fund Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.

Comparable ownership Top 5

Vivo Opportunity Fund Holdings, L.P. 10%

Commodore Capital LP 9.9%

BALYASNY ASSET MANAGEMENT L.P. 9.4%

BIOTECHNOLOGY VALUE FUND L P 9.1%

Caligan Partners LP 8.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Vivo Opportunity Fund Holdings, L.P.	13D/G 13D/G	10%	$89,642,948 22,637,108 shares	-$13,043,812	30 Jun 2026
Commodore Capital LP	13D/G 13F Company 13D/G 13F	9.9%	$35,434,753 8,948,170 shares	+$17,523,764	30 Jun 2026
BALYASNY ASSET MANAGEMENT L.P.	13D/G 13F Company 13D/G 13F	9.4%	$28,612,738 7,225,439 shares	+$8,456,580	30 Jun 2026
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	9.1%	$18,761,910 4,761,906 shares	-$1,598,505	31 Dec 2025
Caligan Partners LP	13D/G 13F Company 13D/G 13F	8.8%	$31,550,140 7,967,207 shares	$0	30 Jun 2026
Adage Capital Management, L.P.	13D/G 13D/G	8.4%	$25,365,990 6,405,553 shares	$0	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

68,397,312

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend